Correlation Between ImmunoCellular Therapeutics and BiOasis Technologies
Can any of the company-specific risk be diversified away by investing in both ImmunoCellular Therapeutics and BiOasis Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ImmunoCellular Therapeutics and BiOasis Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ImmunoCellular Therapeutics and biOasis Technologies, you can compare the effects of market volatilities on ImmunoCellular Therapeutics and BiOasis Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ImmunoCellular Therapeutics with a short position of BiOasis Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of ImmunoCellular Therapeutics and BiOasis Technologies.
Diversification Opportunities for ImmunoCellular Therapeutics and BiOasis Technologies
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between ImmunoCellular and BiOasis is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding ImmunoCellular Therapeutics and biOasis Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on biOasis Technologies and ImmunoCellular Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ImmunoCellular Therapeutics are associated (or correlated) with BiOasis Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of biOasis Technologies has no effect on the direction of ImmunoCellular Therapeutics i.e., ImmunoCellular Therapeutics and BiOasis Technologies go up and down completely randomly.
Pair Corralation between ImmunoCellular Therapeutics and BiOasis Technologies
If you would invest (100.00) in ImmunoCellular Therapeutics on November 29, 2024 and sell it today you would earn a total of 100.00 from holding ImmunoCellular Therapeutics or generate -100.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
ImmunoCellular Therapeutics vs. biOasis Technologies
Performance |
| Timeline |
| ImmunoCellular Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
| biOasis Technologies |
ImmunoCellular Therapeutics and BiOasis Technologies Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ImmunoCellular Therapeutics and BiOasis Technologies
The main advantage of trading using opposite ImmunoCellular Therapeutics and BiOasis Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ImmunoCellular Therapeutics position performs unexpectedly, BiOasis Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BiOasis Technologies will offset losses from the drop in BiOasis Technologies' long position.The idea behind ImmunoCellular Therapeutics and biOasis Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| BiOasis Technologies vs. Biotron Limited | BiOasis Technologies vs. Covalon Technologies | BiOasis Technologies vs. Mosaic Immunoengineering | BiOasis Technologies vs. Cellectis SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |